General Hospital of Thessaloniki Hippokration
Thessaloniki 54642
2 studies enrolling now · 10 studies all time
What they study most
Crohn Disease, Lupus Erythematosus, Systemic, Multiple Sclerosis, Relapsing-Remitting, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Ulcerative Colitis
Studies at this site
- A Study of Obexelimab in Patients With Systemic Lupus Erythematosus — Recruiting now
- Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus — Enrolling by invitation
- A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus — Running, not enrolling
- ABTECT - Maintenance — Running, not enrolling
- The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
- A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis — Running, not enrolling
- Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis — Completed
- Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease — Stopped early
- A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors — Completed